ARTICLE
25 April 2014

Update On Myriad Appeal And Announcing A Public Forum On The USPTO 101 Guidelines

FL
Foley & Lardner

Contributor

Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing our clients and their industries. With over 1,100 lawyers in 24 offices across the United States, Mexico, Europe and Asia, Foley approaches client service by first understanding our clients’ priorities, objectives and challenges. We work hard to understand our clients’ issues and forge long-term relationships with them to help achieve successful outcomes and solve their legal issues through practical business advice and cutting-edge legal insight. Our clients view us as trusted business advisors because we understand that great legal service is only valuable if it is relevant, practical and beneficial to their businesses.
Myriad has appealed the district court decision that denied its motion for a preliminary injunction against Ambry Genetics Corp.
United States Intellectual Property

Myriad has appealed the district court decision that denied its motion for a preliminary injunction against Ambry Genetics Corp. According to a report in Bloomberg BNA Life Sciences Law & Industry Report", on April 14 , 2014, the Federal Circuit denied Myriad's motion to expedite proceedings, but it is still possible that this Myriad appeal will be argued and decided by the end of this calendar year.

Representative claims at issue in this Myriad appeal include claims reciting pairs of single-stranded DNA primers and methods of detecting sequence mutations using one of many laboratory techniques. As discussed in this article, the district court determined that Ambry had "raised a substantial question concerning ... subject matter eligibility." Thus, this appeal could require the Federal Circuit to apply the Supreme Court's Myriad decision to a different set of product and method claims.

Forum on USPTO 101 Guidelines

The USPTO has announced that it is hosting a forum on the 101 Guidelines, in order "to solicit feedback from organizations and individuals." The forum will be held May 9, 2014, from 1:00 to 4:00 pm at the USPTO's headquarters in Alexandria, Virginia.

According to the USPTO press release, Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO Michelle K. Lee stated that "this forum will provide an opportunity for participants to present their interpretation of the impact of Supreme Court precedent on the complex legal and technical issues involved in subject matter eligibility analyses during patent examination." The USPTO is particularly interested in "alternative" approaches to interpreting the relevant Supreme Court decisions (supported by "legal rationale") and "additional examples ... to create a more complete picture of the impact of Supreme Court precedent on subject matter eligibility."

The USPTO is requiring preregistration for the forum, as detailed on the USPTO's subject matter eligibility webpage.

It will be interesting to see what alternatives are suggested, and whether the alternatives take similar or distinct approaches. It also will be interesting to see how many alternatives the USPTO adopts, and how quickly it issues revised guidelines.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More